Lundbeck's Lu AG13909 Secures Orphan Drug Status In US And EU For Rare Adrenal Disorder
24/6 08:53
(RTTNews) - Lundbeck announced that its investigational drug Lu AG13909 received orphan drug designation from the US Food and Drug Administration on 12 May 2025 and from the European Medicines Agency (EMA) on 20 June 2025....